Fundraising Fox

Respicardia

Minnetonka, US · Delaware corporation

Healthtech

Founders & leadership

TW
Thomas WeldonNamed on SEC filing
TH
Timothy HauchNamed on SEC filing
EA
Edward AndrleNamed on SEC filing
WA
William AbrahamNamed on SEC filing
BL
Bonnie LaboskyNamed on SEC filing

Board

BK
B. Kristine JohnsonBoard director
WJ
Wilfred JaegerBoard director
KN
Kirk NielsenBoard director
WJ
Wilf JaegerBoard director
SW
Scott WardBoard director

Reported raises · per SEC filings

Form D private placements

$55.2M disclosed across 4 rounds · 2014–2017

▶$20MraisedDec 2017 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • B. Kristine JohnsonDirector
  • William AbrahamDirector
  • Kirk NielsenDirector
  • Timothy HauchExecutive Officer
  • Wilfred JaegerDirector
  • Bonnie LaboskyExecutive Officer, Director
  • Thomas WeldonDirector
  • Edward AndrleDirector
Offering amount
$40M
Amount sold
$20M
Sales commissions
$875K
Placement agents
Piper Jaffray & Co.
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedJun 2017 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas WeldonDirector
  • B. Kristine JohnsonDirector
  • Timothy HauchExecutive Officer
  • Wilfred JaegerDirector
  • Kirk NielsenDirector
  • Edward AndrleDirector
  • William AbrahamDirector
  • Bonnie LaboskyExecutive Officer, Director
Offering amount
$6.6M
Amount sold
$5.1M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.1MraisedOct 2014 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kirk NielsenDirector
  • B. Kristine JohnsonDirector
  • Wilfred JaegerDirector
  • Bonnie LaboskyExecutive Officer, Director
  • Thomas WeldonDirector
  • Scott WardDirector
  • Timothy HauchExecutive Officer
  • William AbrahamDirector
Offering amount
$25.1M
Amount sold
$25.1M
Sales commissions
$1M
Placement agents
Piper Jaffray & Co.
First sale
Oct 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedAug 2014 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Wilf JaegerDirector
  • William AbrahamDirector
  • B. Kristine JohnsonDirector
  • Bonnie LaboskyExecutive Officer, Director
  • Thomas WeldonDirector
  • Scott WardDirector
  • Kirk NielsenDirector
  • Timothy HauchExecutive Officer
Offering amount
$5M
Amount sold
$5M
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Zoll scores FDA approval for updated sleep apnea implant acquired in Respicardia buyout | Fierce Biotechfiercebiotech.com · Aug 2021Respicardia raises $58.5m to commercialize remede system for CSA treatment - NS Medical Devicesnsmedicaldevices.com · Dec 2017Minnetonka maker of apnea device raises nearly $60 million from investorsstartribune.com · Dec 2017Zoll leads $59m Respicardia funding round - MassDevicemassdevice.com · Dec 2017Respicardia Raises $58M Ahead of Sleep Apnea Product Launch | Twin Cities Businesstcbmag.com · Dec 2017Respicardia Raises $5.1M After Positive Results in Sleep Apnea Trial | Twin Cities Businesstcbmag.com · Jul 2017

Frequently asked questions

How much funding has Respicardia raised?
Respicardia has disclosed $55.2M raised across 4 rounds.
Where is Respicardia headquartered?
Respicardia is headquartered in Minnetonka, US.